Analyses of immune infiltrate in DIPG murine models after treatment with new oncolytic virus Delta-24-ACT
Ontology highlight
ABSTRACT: To better understand the mechanism underlying the therapeutic effect of Delta-24-ACT, we evaluated the triggered immune response. Thus, we intratumorally injected Delta-24-ACT, Delta-24-RGD or PBS (mock group) 3 days after NP53 cell implantation (0D). Then, tumor immune infiltrate was analyzed by NanoString (15 days)
ORGANISM(S): Mus musculus
PROVIDER: GSE197374 | GEO | 2022/05/11
REPOSITORIES: GEO
ACCESS DATA